Blood Advances

@BloodAdvances · Washington, DC · joined 17 May 2016

The Blood Journals Portfolio is consolidating our X accounts. This account will no longer actively post after July 7, 2025. Follow us @bloodportfolio.

31 836Followers

138Following

7 071Posts total

11.3KViews on collected posts

Derniers posts

Blood Advances@BloodAdvances7 Jul 2025

Subpopulations of donor RBCs with low deformability are selectively cleared within 24 hours of transfusion in a murine model. https://t.co/KK5ObpfpEi #redcellsironanderythropoiesis #transfusionmedicine https://t.co/jJ8JEJ37ZC

1.3K views · 3 likes · 1 reposts · 0 replies Open on X →

Blood Advances@BloodAdvances7 Jul 2025

Anti-PF4/heparin and anti-PF4 antibodies can cooperate to induce platelet activation, thrombocytopenia, and thrombus formation. https://t.co/ohhkQTF2KZ #thrombosisandhemostasis https://t.co/bFjmNxR4rz

1.3K views · 5 likes · 2 reposts · 0 replies Open on X →

Blood Advances@BloodAdvances7 Jul 2025

@BloodAdvances The statement you've highlighted is quite intriguing, especially in the context of hematology and myeloid neoplasia. It seems to underscore the distinct impact of different mutations on hematopoietic stem and progenitor cells (HSPCs) with the SF3B1 mutation. I wond 24 views · 0 likes · 0 reposts · 0 replies Open on X →

Blood Advances@BloodAdvances7 Jul 2025

High-risk RUNX1 and STAG2, but not low-risk TET2, mutations selectively expand different compartments of SF3B1-mutant primitive HSPCs. https://t.co/UGDvJUJzKk #myeloidneoplasia https://t.co/v69YMGpDaf

2.6K views · 26 likes · 5 reposts · 1 replies Open on X →

Blood Advances@BloodAdvances6 Jul 2025

AhR ligand treatment ameliorates CNS GVHD by reducing NF-κB signaling in microglia thereby providing a novel therapeutic target. https://t.co/CLkqiPkjXu #transplantation #immunobiologyandimmunotherapy https://t.co/NbO9g8cALW

2.3K views · 18 likes · 3 reposts · 1 replies Open on X →

Blood Advances@BloodAdvances13 Jun 2025

🚨📣The Blood Journals Portfolio is consolidating our X accounts. Please follow us at @BloodPortolio. This account will no longer actively post after July 7, 2025. #BloodPortolio #BloodJournals https://t.co/imWb8Evx2R

3.8K views · 4 likes · 1 reposts · 0 replies Open on X →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.8K13 Jun

2.3K6 Jul

2.6K7 Jul

1.3K

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.13%13 Jun

0.96%6 Jul

1.24%7 Jul

0.00%

0.53%

0.31%

Reactions — likes, reposts, replies and quotes — divided by views.

What the audience does

Likes65.1%56 in total

Reposts14.0%12 in total

Replies2.3%2 in total

Bookmarks18.6%16 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Derniers posts

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Comptes similaires